TransTACs: Transforming antibodies into targeted protein degraders

被引：0
|
作者：
Guo, Yu [1 ,2 ]
Che, Jinxin [1 ,2 ]
Dong, Xiaowu [1 ,2 ]
机构：
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China
[2] Zhejiang Univ, State Key Lab Adv Drug Delivery & Release Syst, Hangzhou 310058, Peoples R China
来源：
ACTA PHARMACEUTICA SINICA B | 2025年 / 15卷 / 02期
关键词：
Targeted protein degradation; Membrane and extracellular proteins; Transferrin receptor-targeting chimeras; Protein homeostasis regulation; Tumor therapy; DEGRADATION; PROTACS;
D O I：
10.1016/j.apsb.2025.01.003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1186 / 1188
页数：3
相关论文
共 50 条
  • [31] Targeted protein degraders: a call for collective action to advance safety assessment
    Jones, Lyn H.
    Mitchell, Constance A.
    Loberg, Lise
    Pavkovic, Mira
    Rao, Mohan
    Roberts, Ruth
    Stamp, Katie
    Volak, Laurie
    Wittwer, Matthias B.
    Pettit, Syril
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (06) : 401 - 402
  • [32] Biologics-based degraders - an expanding toolkit for targeted-protein degradation
    VanDyke, Derek
    Taylor, Jonathan D.
    Kaeo, Kyle J.
    Hunt, James
    Spangler, Jamie B.
    CURRENT OPINION IN BIOTECHNOLOGY, 2022, 78
  • [33] Development of natural product-based targeted protein degraders as anticancer agents
    Chen, Cheng
    Feng, Yanyan
    Zhou, Chen
    Liu, Zhouyan
    Tang, Ziwei
    Zhang, Ye
    Li, Tong
    Gu, Chenglei
    Chen, Jichao
    BIOORGANIC CHEMISTRY, 2024, 153
  • [34] Discovery of new targeted protein degraders using DNA-encoded chemistry
    Keefe, Anthony D.
    Disch, Jeremy S.
    Duffy, Jennifer
    Lee, Esther C.
    Gikunju, Diana
    Chan, Betty
    Levin, Benjamin D.
    Monteiro, Michael I.
    Talcott, Sarah A.
    Lau, Anthony
    Zhou, Fei
    Kozhushnyan, Anton
    Westlund, Neil E.
    Mullins, Patrick B.
    Yu, Yan
    Von Rechenberg, Moritz
    Zhang, Junyi
    Arnautova, Yelena
    Liu, Yanbin
    Zhang, Ying
    McRiner, Andrew J.
    Kohlmann, Anna
    Clark, Matthew A.
    Cuozzo, John W.
    Huguet, Christelle
    Arora, Shilpi
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Bifunctional Compounds as Molecular Degraders for Integrin- Facilitated Targeted Protein Degradation
    Zheng, Jiwei
    He, Wanyi
    Li, Jing
    Feng, Xuejia
    Li, Yanyan
    Cheng, Binghua
    Zhou, Yimin
    Li, Meiqing
    Liu, Ke
    Shao, Ximing
    Zhang, Jianchao
    Li, Hongchang
    Chen, Liang
    Fang, Lijing
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (48) : 21831 - 21836
  • [36] Cure-PROs: Next-generation targeted protein degraders.
    Giardina, Sarah F.
    Valdambrini, Elena
    Peel, Michael
    Bacolod, Manny D.
    Rothenberg, Mace L.
    Lanman, Richard B.
    Warren, J. David
    Barany, Francis
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?
    Ambrosini, Margherita
    Fuca, Giovanni
    Duca, Matteo
    Damian, Silvia
    De Santis, Francesca
    Corti, Francesca
    Cresta, Sara
    de Braud, Filippo
    Di Nicola, Massimo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 169
  • [38] Simplifying Access to Targeted Protein Degraders via Nickel Electrocatalytic Cross-Coupling
    Neigenfind, Philipp
    Massaro, Luca
    Peter, Aron
    Degnan, Andrew P.
    Emmanuel, Megan A.
    Oderinde, Martins S.
    He, Chi
    Peters, David
    El-Hayek Ewing, Tamara
    Kawamata, Yu
    Baran, Phil S.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (16)
  • [39] PK/PD modeling of targeted protein degraders: Charting new waters and navigating the shallows
    Haid, Robin T. U.
    Reichel, Andreas
    DRUG DISCOVERY TODAY, 2025, 30 (03)
  • [40] Targeted degraders clear first safety hurdles
    Asher Mullard
    Nature Reviews Drug Discovery, 2020, 19 (7) : 435 - 435
12345